Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-256
Closed -$9K 1972
2022
Q1
$9K Sell
256
-15
-6% -$515 ﹤0.01% 1617
2021
Q4
$11K Buy
271
+31
+13% +$1.29K 0.01% 1657
2021
Q3
$10K Sell
240
-168
-41% -$7.54K 0.01% 1026
2021
Q2
$17K Buy
+408
New +$15.7K 0.01% 953

Other funds holding GMAB

State of Wyoming's GMAB Position: Q2 2022 in Review

State of Wyoming sold out of Genmab (GMAB) in Q2 2022, closing a stake of 256 shares — an estimated $9K sold.

State of Wyoming first reported a position in GMAB in Q2 2021 and held it in 4 quarters. The position peaked at $17K in Q2 2021. 180 funds tracked by Wall St. Rank hold GMAB as of Q2 2022.

  • State of Wyoming reported no remaining Genmab position as of Q2 2022 after selling out during the quarter.
  • State of Wyoming sold 256 Genmab shares in Q2 2022, an estimated $9K.
  • State of Wyoming first reported a position in Genmab in Q2 2021 and held it in 4 quarters.
  • State of Wyoming's Genmab position peaked at $17K in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Genmab as of Q2 2022.

Based on State of Wyoming's 13F filing for Q2 2022, filed 15 Aug 2022.